α-synuclein stimulates differentiation of osteosarcoma cells -: Relevance to down-regulation of proteasome activity

被引:34
|
作者
Fujita, Masayo
Sugama, Shuei
Nakai, Masaaki
Takenouchi, Takato
Wei, Jianshe
Urano, Tomohiko
Inoue, Satoshi
Hashimoto, Makoto
机构
[1] Tokyo Metropolitan Inst Neurosci, Lab Chem & Metab, Fuchu, Tokyo 1838526, Japan
[2] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki 3058634, Japan
[3] Univ Tokyo, Sch Med, Dept Geriatr & Gerontol, Tokyo 1138655, Japan
关键词
D O I
10.1074/jbc.M606175200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because a limited study previously showed that alpha-synuclein (alpha-syn), the major pathogenic protein for Parkinson disease, was expressed in differentiating brain tumors as well as various peripheral cancers, the main objective of the present study was to determine whether a-syn might be involved in the regulation of tumor differentiation. For this purpose, a-syn and its non-amyloidogenic homologue beta-syn were stably transfected to human osteosarcoma MG63 cell line. Compared with beta-syn-overexpressing and vector-transfected cells, alpha-syn-overexpressing cells exhibited distinct features of differentiated osteoblastic phenotype, as shown by up-regulation of alkaline phosphatase and osteocalcin as well as inductive matrix mineralization. Further studies revealed that proteasome activity was significantly decreased in a-syn-overexpressing cells compared with other cell types, consistent with the fact that proteasome inhibitors stimulate differentiation of various osteoblastic cells. In a-syn-overexpressing cells, protein kinase C (PKC) activity was significantly decreased, and reactivation of PKC by phorbol ester significantly restored the proteasome activity and abrogated cellular differentiation. Moreover, activity of lysosome was up-regulated in a-syn-overexpressing cells, and treatment of these cells with autophagy-lysosomal inhibitors resulted in a decrease of proteasome activity associated with up-regulation of a-syn expression, leading to enhance cellular differentiation. Taken together, these results suggest that the stimulatory effect of a-syn on tumor differentiation may be attributed to down-regulation of proteasome, which is further modulated by alterations of various factors, such as protein kinase C signaling pathway and a autophagy-lysosomal degradation system. Thus, the mechanism of a-syn regulation of tumor differentiation and neuropathological effects of a-syn may considerably overlap with each other.
引用
收藏
页码:5736 / 5748
页数:13
相关论文
共 50 条
  • [31] SCLEROSTIN DOWN-REGULATION STIMULATES BROWNING OF HUMAN BM-MSCS
    Gurt, I.
    El-Haj, M.
    Artsi, H.
    Cohen-Kfir, E.
    Safran, O.
    Dresner-Pollak, R.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S379 - S379
  • [32] Reversible down-regulation of telomerase activity.
    Dana, RC
    Dana, EP
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 428A - 428A
  • [33] DOWN-REGULATION OF NMDA RECEPTOR ACTIVITY BY NMDA
    OSTER, Y
    SCHRAMM, M
    NEUROSCIENCE LETTERS, 1993, 163 (01) : 85 - 88
  • [34] KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation
    Huard, B
    Karlsson, L
    Triebel, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (06) : 1728 - 1735
  • [35] Down-regulation of telomerase activity by anticancer drugs in human ovarian cancer cells
    Kunifuji, Y
    Gotoh, S
    Abe, T
    Miura, M
    Karasaki, Y
    ANTI-CANCER DRUGS, 2002, 13 (06) : 595 - 598
  • [36] Down-regulation of E protein activity augments an ILC2 differentiation program in the thymus
    Sun, Xiao-Hong
    Wang, Hong-Cheng
    Qian, Miranda Liangyue
    Zhao, Ying
    Zhuang, Yuan
    Urban, Joseph F.
    Fung, Kar-Ming
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [37] Proteasome-dependent down-regulation of activated Stat5A in the nucleus
    Chen, Yuhong
    Dai, Xuezhi
    Haas, Arthur L.
    Wen, Renren
    Wang, Demin
    BLOOD, 2006, 108 (02) : 566 - 574
  • [38] HDAC inhibition prevents NF-κB activation by suppressing proteasome activity:: Down-regulation of proteasome subunit expression stabilizes IκBα
    Place, RF
    Noonan, EJ
    Giardina, C
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (03) : 394 - 406
  • [39] Down-regulation of matrix metalloproteinases in explanted-IOLs and HLE B-3 cells by proteasome inhibition
    Wang-Su, ST
    Wagner, BJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [40] Down-regulation of osteoclast differentiation by daidzein via caspase 3
    Rassi, CM
    Lieberherr, M
    Chaumaz, G
    Pointillart, A
    Cournot, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (04) : 630 - 638